Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective

Y Yang, S Li, Y Wang, Y Zhao, Q Li - Signal transduction and targeted …, 2022 - nature.com
Protein tyrosine kinases (PTKs) are a class of proteins with tyrosine kinase activity that
phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal …

Precision medicine: disease subty** and tailored treatment

RC Wang, Z Wang - Cancers, 2023 - mdpi.com
Simple Summary The genomics-based concept of precision medicine began to emerge
following the completion of the Human Genome Project. In contrast to evidence-based …

[HTML][HTML] Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer

W Mao, Y Cai, D Chen, G Jiang, Y Xu, R Chen… - JCI insight, 2022 - ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) therapy has achieved breakthroughs in the treatment of
advanced non–small cell lung cancer (NSCLC). Nevertheless, the low response due to …

Dysregulated signalling pathways driving anticancer drug resistance

N Bou Antoun, AM Chioni - International journal of molecular sciences, 2023 - mdpi.com
One of the leading causes of death worldwide, in both men and women, is cancer. Despite
the significant development in therapeutic strategies, the inevitable emergence of drug …

Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy

S Li, A Wang, Y Wu, S He, W Shuai… - Immunological …, 2024 - Wiley Online Library
Non‐small‐cell lung cancer (NSCLC), which has a high rate of metastatic spread and drug
resistance, is the most common subtype of lung cancer. Therefore, NSCLC patients have a …

Cholesterol metabolism in cancer and cell death

F Chen, Y Lu, J Lin, R Kang, J Liu - Antioxidants & Redox Signaling, 2023 - liebertpub.com
Significance: Cholesterol is a type of lipid that plays a crucial role in building and
maintaining cell membranes, producing certain hormones, and aiding in digestion. The two …

The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy

H Hu, W Li, Y Hao, Z Peng, Z Zou, J Wei, Y Zhou… - Cell Reports …, 2024 - cell.com
Hyperuricemic nephropathy (HN) is a global metabolic disorder characterized by uric acid
(UA) metabolism dysfunction, resulting in hyperuricemia (HUA) and tubulointerstitial fibrosis …

m6A-Mediated Induction of 7-Dehydrocholesterol Reductase Stimulates Cholesterol Synthesis and cAMP Signaling to Promote Bladder Cancer Metastasis

Y Zeng, Y Luo, K Zhao, S Liu, K Wu, Y Wu, K Du… - Cancer …, 2024 - aacrjournals.org
Dysregulation of cholesterol homeostasis occurs in multiple types of tumors and promotes
cancer progression. Investigating the specific processes that induce abnormal cholesterol …

Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations

Q He, M Qu, H Bao, Y Xu, T Shen, D Tan… - Cytokine & Growth …, 2023 - Elsevier
Epidermal growth factor receptor (EGFR) mutation is the most common driver mutation in
non-small cell lung cancer (NSCLC). The first-line therapy for advanced NSCLC patients …

[HTML][HTML] Targeting lipid metabolism of macrophages: A new strategy for tumor therapy

N Shao, H Qiu, J Liu, D **ao, J Zhao, C Chen… - Journal of Advanced …, 2024 - Elsevier
Background Lipid metabolism has been implicated in a variety of normal cellular processes
and strongly related to the development of multiple diseases, including tumor. Tumor …